Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 141, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2022.104814
Keywords
Gut microbiome; Alzheimer disease; Age; Lifestyle; Prevention
Categories
Funding
- National Institute of Health [NIH R21-AG067755]
- University of New Mexico Grand Challenges Initiative
- NIH [P20-AG068077]
Ask authors/readers for more resources
Alterations in the gut microbiome, known as gut dysbiosis, play a potential key role in neurodegeneration and Alzheimer's disease pathogenesis via the gut-brain axis. Gut dysbiosis influences neuroinflammation, immune dysregulation, protein aggregation, and barrier permeability, leading to cognitive impairment and neuronal loss. Additionally, characteristic gut microbial signatures in AD patients may serve as potential markers for disease severity and progression.
Structural and functional alterations to the gut microbiome, referred to as gut dysbiosis, have emerged as potential key mediators of neurodegeneration and Alzheimer disease (AD) pathogenesis through the gut -brain axis. Emerging data from animal and clinical studies support an important role for gut dysbiosis in mediating neuroinflammation, central and peripheral immune dysregulation, abnormal brain protein aggregation, and impaired intestinal and brain barrier permeability, leading to neuronal loss and cognitive impairment. Gut dysbiosis has also been shown to directly influence various mechanisms involved in neuronal growth and repair, synaptic plasticity, and memory and learning functions. Aging and lifestyle factors including diet, exercise, sleep, and stress influence AD risk through gut dysbiosis. Furthermore, AD is associated with characteristic gut microbial signatures which offer value as potential markers of disease severity and progression. Together, these findings suggest the presence of a complex bidirectional relationship between AD and the gut microbiome and highlight the utility of gut modulation strategies as potential preventative or therapeutic strategies in AD. We here review the current literature regarding the role of the gut-brain axis in AD pathogenesis and its potential role as a future therapeutic target in AD treatment and/or prevention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available